iodixanol has been researched along with Cardiometabolic Syndrome in 2 studies
iodixanol: dimeric contrast media; structure given in first source
iodixanol : A dimeric, non-ionic, water-soluble, radiographic contrast agent, used particularly in coronary angiography.
Cardiometabolic Syndrome: A cluster of symptoms that are risk factors for CARDIOVASCULAR DISEASES and TYPE 2 DIABETES MELLITUS. The major components not only include metabolic dysfunctions of METABOLIC SYNDROME but also HYPERTENSION, and ABDOMINAL OBESITY.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pop, R | 1 |
| Kong, SH | 1 |
| Langlois, A | 1 |
| Marchegiani, F | 1 |
| Shlomovitz, E | 1 |
| Legnèr, A | 1 |
| Bietiger, W | 1 |
| Pinget, M | 1 |
| Beaujeux, R | 1 |
| Mutter, D | 1 |
| Marescaux, J | 1 |
| Diana, M | 1 |
| Butler, J | 1 |
| Mooyaart, EA | 1 |
| Dannemann, N | 1 |
| Bamberg, F | 1 |
| Shapiro, MD | 1 |
| Ferencik, M | 1 |
| Brady, TJ | 1 |
| Hoffmann, U | 1 |
2 other studies available for iodixanol and Cardiometabolic Syndrome
| Article | Year |
|---|---|
Gastrointestinal Hormones Manipulation to Counteract Metabolic Syndrome Using Duodenal Targeted Embolization.
Topics: Angiography, Digital Subtraction; Animals; Contrast Media; Disease Models, Animal; Duodenum; Emboliz | 2019 |
Relation of the metabolic syndrome to quantity of coronary atherosclerotic plaque.
Topics: Calcinosis; Contrast Media; Coronary Angiography; Coronary Artery Disease; Female; Humans; Male; Met | 2008 |